Given the growing evidence of TG2’s role in AD [28,30,31,32,33,34] and the neuroprotective effects of gelsemine in AD models [11], we hypothesize that a functional interaction between gelsemine and TG2 may underlie its beneficial actions in AD. Here, TGM2 is linked to Alzheimer disease.